Questcor Pharmaceuticals Inc. was formed on November 17, 1999 when Cypros Pharmaceutical Corporation and RiboGene Inc. merged to become one integrated company. See below for some key dates, milestones, and accomplishments from our history.
| Company Timeline | |
|---|---|
| 1999 | Formation of Questcor through merger of RiboGene Inc. and Cypros Pharmaceutical Corporation |
| 2001 | Questcor acquires Acthar® Gel from Aventis |
| 2005 | Questcor divests Nascobal®, Glofil® and Ethamolin® to QOL Medical |
| 2007 | Questcor initiates new orphan strategy for Acthar Questcor dramatically expands funding for patient assistance programs First profitable year in Questcor's history |
| 2008 | Questcor moves to NASDAQ Questcor initiates effort to evaluate Acthar in nephrotic syndrome Questcor submits sNDA for IS indication to FDA Questcor records second consecutive profitable year |
| 2010 | Questcor receives FDA approval for Acthar in the treatment of infantile spasms |
| 2011 | Questcor initiates effort to evaluate Acthar in Rheumatology Forbes Magazine ranks Questcor as America’s #1 Small Company |
| 2012 | Questcor receives CNF 2012 Corporate Citizenship Award |
